Delivery Order SPE2DB22D3301-SPE2DB25FZ0UV
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $22,765.02 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-unit quantity) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion...
- The Defense Logistics Agency awarded a delivery order valued at $34,348.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $21,218.77. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract ceiling value of $26,755.38. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 10,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $42,178.80. This firm fixed-price delivery order, which is set to be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count units) valued at $13,624.62 on April 10, 2025, with completion scheduled for April 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026....
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0UVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on September 10, 2025, with a ceiling value of $12,412.98 under a firm fixed-price contract. This award represents a non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's extensive federal contract portfolio with the DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, specialty drugs, vaccines, and medical devices. This delivery order for Eliquis—an anticoagulant medication—exemplifies the routine pharmaceutical supply fulfillment that AmerisourceBergen executes through its prime IDC to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 9/10/25 |